Dr. Friedhoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
123 E 37th St.
New York, NY 10016
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1981 - 1982
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1977 - 1978
New York University School of MedicineClass of 1977
Certifications & Licensure
NY State Medical License 1978 - 2025
NJ State Medical License 1982 - 2005- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study of SkQ1 as Treatment for Dry-eye Syndrome Start of enrollment: 2018 Dec 06
Publications & Presentations
PubMed
- 576 citationsDonepezil Improves Cognition and Global Function in Alzheimer Disease A 15-Week, Double-blind, Placebo-Controlled StudySharon L. Rogers, Rachelle S. Doody, Richard C. Mohs, Lawrence T. Friedhoff
Archives of Internal Medicine. 1998-05-11 - 515 citationsThe efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trialSharon L. Rogers, Lawrence T. Friedhoff
Dementia. 1996-11-01 - 38 citationsThe effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarinP J Tiseo, K Foley, Lawrence T. Friedhoff
British Journal of Clinical Pharmacology. 1998-11-01
Books/Book Chapters
Press Mentions
INmune Bio Doses First Alzheimer’s Disease Patient in XPro1595 StudyDecember 2nd, 2019
INmune Bio Inc. To Discuss Potential New Alzheimer’s Disease Treatments in CTAD Pre-Conference WebinarNovember 26th, 2019
Axovant to Present Patient Function and Independence Data Analyses from Phase 2b Study of Investigational Treatment Intepirdine in Alzheimer’s Disease at CTAD 2016December 5th, 2016- Join now to see all
Professional Memberships
- Fellow
Industry Relationships
- Head of Research and Development, Roivant Sciences, Inc.One of four original employees. Designer of the unique management structure which has proved to provide more efficient/effective FDA approvals.2014 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
